Our clients are suing five of the world’s largest pharmaceutical and medical-supply companies for allegedly funding Shiite terrorists in Iraq through a sophisticated bribery scheme.
As alleged, this scheme – aimed at increasing the companies’ market share and profits – provided funding for a Shiite terrorist group that carried out attacks that killed and wounded thousands of Americans in Iraq.
In July 2018, it was publicly reported that the U.S. Government is now “investigating claims that drug companies funded terrorism in Iraq,” one or more defendants have “received an inquiry from the U.S. Department of Justice in connection with an anti-corruption investigation relating to activities in Iraq,” and at least one defendant has claimed that DOJ’s inquiry is related to the Anti-Terrorism Act case brought by our clients.
We represent, or seek to represent, Americans who were attacked or who have a family member who was attacked, by Shiite terrorists in Iraq from June 2005 through the present. We believe these terrorists were supported by the defendants’ corrupt payments.
Jaysh al-Mahdi (also known as JAM or the Mahdi Army) was a radical anti-U.S. militia that targeted, injured, and killed Americans in the years following the 2003 invasion of Iraq. Jaysh al-Mahdi was led by Muqtada al-Sadr, an Iraqi cleric and political figure notorious for his fiery anti-American rhetoric and brutal attacks on Americans serving in Iraq. This was widely known in Iraq and reported by major news organizations around the world.
Our clients’ complaint alleges that Jaysh al-Mahdi’s terrorist attacks against Americans in Iraq were planned, authorized, and sometimes conducted by Hezbollah, the militant Lebanese terrorist group designated as a Foreign Terrorist Organization by the U.S. State Department and responsible for the most lethal terrorist attack against America before 9/11. In April 2003, Hezbollah dispatched its chief terrorist mastermind, Imad Mugniyeh, to Iraq to help Sadr establish Jaysh al-Mahdi. Mugniyeh and other Hezbollah operatives subsequently recruited, trained, and equipped Jaysh al-Mahdi terrorists to carry out attacks against Americans in Iraq. Hezbollah’s training, weapons, and personnel were essential to Jaysh al-Mahdi’s terrorist campaign. As one prominent embedded war correspondent reported in 2007: “The Mahdi Army is Iran’s proxy in Iraq. It is, in effect, the Iraqi branch of Hezbollah.” As thousands of Jaysh al-Mahdi terrorists themselves declared, while marching under Hezbollah banners in 2006: “We are Hezbollah.”
Beginning in 2004, Jaysh al-Mahdi terrorists took control of Iraq’s Health Ministry and began using the ministry to raise money for terrorist attacks.
Despite the well-known and well-documented connection between the Iraqi Health Ministry and Jaysh al-Mahdi terrorists, our clients’ complaint alleges that large American and European companies bribed these terrorists to win contracts to increase their profits. As alleged, Jaysh al-Mahdi terrorists then used the bribes to fund attacks against Americans. Our complaint alleges that these bribes still happen today, and continue to support Shiite terrorists who remain a threat to Americans in Iraq.
Our case was filed on October 17, 2017, in the U.S. District Court for the District of Columbia in Washington, D.C. on behalf of more than 100 Americans, including veterans, their family members, and the survivors of U.S. military and civilian personnel injured or killed in Jaysh al-Mahdi attacks. In an amended complaint filed on March 12, 2018, more than 200 additional Americans joined the case as plaintiffs.
Our case alleges that the defendants have paid bribes as a matter of course in Iraq since the days of Saddam, and that they continued to do so after Saddam was overthrown and Jaysh al-Mahdi terrorists seized the Iraqi Health Ministry. Many of the defendants we have sued have admitted to paying bribes to Iraqi Health Ministry officials in the past, paid millions of dollars to settle such allegations, or have been found to have made such corrupt payments by an independent investigation.
The defendants being sued are the parent companies and/or subsidiaries of AstraZeneca plc, General Electric Co., Johnson & Johnson, Pfizer Inc., and Roche Holding Ltd. In response to our complaint, the defendants have argued, among other things, that Jaysh al-Mahdi is not a “terrorist organization” and thus that the American families in this case cannot hold the defendants accountable under the Anti-Terrorism Act even if it is true that the defendants paid large bribes to Jaysh al-Mahdi members to win big contracts from the Iraqi Ministry of Health. We strongly disagree with the defendants’ argument that a corporation cannot be held legally responsible under the Anti-Terrorism Act even if it paid millions directly to Jaysh al-Mahdi when the terrorist group was regularly attacking Americans, and this is one of the things we believe our case is about.
We believe that each defendant paid bribes to Jaysh al-Mahdi terrorists who controlled the Iraqi Health Ministry in numerous ways, including but not limited to, cash bribes known in Iraq as “commissions,” “free goods” bribes structured to make it easier for the terrorists to resell those goods for cash on the black market, and several other corrupt schemes several defendants have historically pursued in Iraq, the Middle East and elsewhere. We believe the evidence will show that by providing cash, “free goods,” and other corrupt payments to Jaysh al-Mahdi terrorists at the Iraqi Health Ministry, the defendants knew or recklessly disregarded that their corrupt payments would help fund attacks against Americans in Iraq.